동물용 혈액 분석기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 분석 파라미터별, 생물종별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Veterinary Hematology Analyzers Market Growth & Trends:

The global veterinary hematology analyzers market size is anticipated to reach USD 2.12 billion by 2030 and is projected to grow at a CAGR of 10.0% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is primarily driven by growing animal population and ownership rates, increased expenditure on animals, an increasing focus on preventative animal healthcare, advances in veterinary molecular diagnostic testing, and rising R&D investment in animal health diagnostics to launch innovative products. For instance, in January 2024, Center Point Bio-Tech (CPB) launched AlphaION, a next-generation veterinary diagnostic system, at the 2024 Veterinary Meeting & Expo, exceeding order expectations. AlphaION combines lab automation, AI, and modular components for streamlined blood, fecal, urine, and bacterial testing at the point of care. Future developments include holographic cell reconstruction for enhanced hematology accuracy, eliminating reagent packs, and reducing maintenance needs.

The rising prevalence of animal diseases and growing pet ownership drive the veterinary hematology analyzers industry. According to the World Organisation for Animal Health (WOAH), over 20% of livestock losses globally are due to diseases, increasing the need for early and accurate diagnostic testing. In addition, the surge in companion animal ownership, with nearly 70% of U.S. households owning pets, drives the demand for advanced diagnostic tools in veterinary clinics. The increasing focus on preventive healthcare and regular wellness screenings further boosts the adoption of hematology analyzers for early disease detection and monitoring.

The growing demand for accurate and rapid diagnostics is boosting the adoption of 5-part analyzers in specialty veterinary laboratories. Veterinary hematology analyzers play a key role in conducting CBC tests to monitor animal health by analyzing RBC, PLT, and WBC counts. While 3-part analyzers are cost-effective and sufficient for general screenings, 5-part analyzers offer enhanced accuracy by differentiating WBC into five subtypes, making them ideal for complex cases. 4-part analyzers provide a balance, offering eosinophil differentiation without the higher cost of 5-part devices. Advanced models, like Boule's Exigo H400, combine low maintenance, cost efficiency, and high accuracy, making them suitable for veterinary clinics and labs.

Key market trends include automation, point-of-care testing (POCT), and multi-parameter analysis. The shift towards POCT analyzers that deliver real-time results is gaining traction, allowing veterinarians to make faster clinical decisions. Moreover, the development of compact, portable hematology analyzers with enhanced sensitivity and specificity is expanding their adoption in rural and mobile veterinary practices. As AI and machine learning continue to refine diagnostic accuracy, the veterinary hematology analyzer industry is expected to witness sustained growth, driven by demand for rapid, accurate, and cost-effective diagnostics.

Veterinary Hematology Analyzers Market Report Highlights:

• The Point-of-care analyzers segment led the market with the largest revenue share of 61.45% in 2024, due to rapid diagnostics, ease of use, and growing demand for on-site testing. It is expected to grow at the fastest CAGR of 10.4% during the forecast period, driven by rising veterinary clinics and improved patient outcomes.
• Based on species, the canine segment accounted for the largest market revenue share in 2024, due to the high prevalence of canine diseases, increasing pet ownership, and frequent diagnostic testing. However, the feline segment is projected to grow at the fastest CAGR from 2025 to 2030, owing to rising feline adoption rates, growing awareness of feline health, and increased veterinary expenditures on cats.
• Based on analysis parameters, the 5-part WBC differential segment accounted for the largest market revenue share in 2024, due to its greater accuracy and detailed leukocyte analysis, aiding in the precise diagnosis of complex diseases. The other parameters segment is projected to grow at the fastest CAGR during the forecast period, due to rising demand for advanced diagnostic capabilities, including reticulocyte counts and nucleated red blood cells, enhancing disease detection accuracy.
• Based on end use, the veterinary laboratories segment accounted for the largest market revenue share in 2024, owing to the high testing volume, advanced diagnostic capabilities, and access to skilled professionals, ensuring accurate and comprehensive results. Conversely, the Point-Of-Care Testing (POCT) segment is expected to grow at the highest CAGR due to its rapid turnaround time, convenience, and increasing adoption of portable analyzers for immediate on-site diagnostics.
• North America dominated the market with the largest revenue share of 52.85% in 2024. Conversely, the Asia Pacific region is anticipated to grow at the fastest CAGR of 12.7% during the forecast period.
• Increasing pet insurance coverage and rising expenditure on animal healthcare drive the demand for advanced veterinary diagnostics, creating growth opportunities for veterinary hematology analyzers.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Regional Scope
  • 1.1.2. Estimates and Forecast Timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis
  • 1.6.2. Global Market: CAGR Calculation
• 1.7. Research Scope and Assumptions
  • 1.7.1. List of Secondary Sources
  • 1.7.2. List of Primary Sources
  • 1.7.3. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Veterinary Hematology Analyzers Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
  • 3.2.2. Market Restraints Analysis
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenges Analysis
• 3.3. Veterinary Hematology Analyzers Market Analysis Tools
  • 3.3.1. Porter's Analysis
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental Landscape
    • 3.3.2.5. Legal landscape
• 3.4. Pricing Analysis
• 3.5. Technology landscape
• 3.6. Estimated Animal Population by Key Countries and by key species

Chapter 4. Veterinary Hematology Analyzers Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Veterinary Hematology Analyzers Market Movement Analysis
• 4.3. Global Veterinary Hematology Analyzers Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Table-top analyzers
  • 4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Fully automatic analyzers
    • 4.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.3. Semi-automatic analyzers
    • 4.4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 4.5. Point-of-care analyzers
  • 4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5.2. Cartridge based analyzers
    • 4.5.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5.3. Direct sample-based analyzers
    • 4.5.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Veterinary Hematology Analyzers Market: Species Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Veterinary Hematology Analyzers Market Movement Analysis
• 5.3. Global Veterinary Hematology Analyzers Market Size & Trend Analysis, by Species, 2018 to 2030 (USD Million)
• 5.4. Cattle
  • 5.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.5. Canine
  • 5.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.6. Feline
  • 5.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.7. Caprine
  • 5.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.8. Equine
  • 5.8.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.9. Ovine
  • 5.9.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.10. Porcine
  • 5.10.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.11. Avian
  • 5.11.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.12. Others
  • 5.12.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Veterinary Hematology Analyzers Market: Analysis Parameters Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Veterinary Hematology Analyzers Market Movement Analysis
• 6.3. Global Veterinary Hematology Analyzers Market Size & Trend Analysis, Analysis Parameters, 2018 to 2030 (USD Million)
• 6.4. 3-part WBC differential
  • 6.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.5. 5-part WBC differential
  • 6.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.6. Other parameters
  • 6.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Veterinary Hematology Analyzers Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Veterinary Hematology Analyzers Market Movement Analysis
• 7.3. Global Veterinary Hematology Analyzers Market Size & Trend Analysis, End Use, 2018 to 2030 (USD Million)
• 7.4. Veterinary Hospitals & Clinics
  • 7.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.5. Veterinary Laboratories
  • 7.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.6. Point-Of-Care Testing
  • 7.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.7. Others
  • 7.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Veterinary Hematology Analyzers Market: Regional Estimates & Trend Analysis

• 8.1. Regional Dashboard
• 8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030 North America
• 8.3. North America
  • 8.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. U.S. Veterinary Hematology Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Canada Veterinary Hematology Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Mexico Veterinary Hematology Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.4. Europe
  • 8.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.2. UK
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. UK Veterinary Hematology Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Germany Veterinary Hematology Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. France Veterinary Hematology Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Italy Veterinary Hematology Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Spain Veterinary Hematology Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.7. Sweden
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Sweden Veterinary Hematology Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.8. Denmark
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Denmark Veterinary Hematology Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Norway Veterinary Hematology Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. China
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. China Veterinary Hematology Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. Japan
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Japan Veterinary Hematology Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. India Veterinary Hematology Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. South Korea Veterinary Hematology Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.6. Australia
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Australia Veterinary Hematology Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.7. Thailand
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Thailand Veterinary Hematology Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.6. Latin America
  • 8.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Brazil Veterinary Hematology Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Argentina Veterinary Hematology Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.7. Middle East and Africa
  • 8.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.7.2. Saudi Arabia
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Saudi Arabia Veterinary Hematology Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.3. South Africa
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. South Africa Veterinary Hematology Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.4. UAE
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. UAE Veterinary Hematology Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Kuwait Veterinary Hematology Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Company Market Position Analysis/ Heat Map Analysis
• 9.3. Estimated Company Market Share Analysis, 2024
• 9.4. Strategy Mapping
  • 9.4.1. Mergers & Acquisitions
  • 9.4.2. Partnerships & Collaborations
  • 9.4.3. Others
• 9.5. Company Profiles
  • 9.5.1. IDEXX Laboratories, Inc.
    • 9.5.1.1. Participant's Overview
    • 9.5.1.2. Financial Performance
    • 9.5.1.3. Product Benchmarking
    • 9.5.1.4. Strategic Initiatives
  • 9.5.2. Zoetis
    • 9.5.2.1. Participant's Overview
    • 9.5.2.2. Financial Performance
    • 9.5.2.3. Product Benchmarking
    • 9.5.2.4. Strategic Initiatives
  • 9.5.3. Mars Inc. (Heska Corporation)
    • 9.5.3.1. Participant's Overview
    • 9.5.3.2. Financial Performance
    • 9.5.3.3. Product Benchmarking
    • 9.5.3.4. Strategic Initiatives
  • 9.5.4. HORIBA Medical
    • 9.5.4.1. Participant's Overview
    • 9.5.4.2. Financial Performance
    • 9.5.4.3. Product Benchmarking
    • 9.5.4.4. Strategic Initiatives
  • 9.5.5. Scitek Global Co., Ltd.
    • 9.5.5.1. Participant's Overview
    • 9.5.5.2. Financial Performance
    • 9.5.5.3. Product Benchmarking
    • 9.5.5.4. Strategic Initiatives
  • 9.5.6. Shenzhen Mindray Animal Medical Technology Co., LTD.
    • 9.5.6.1. Participant's Overview
    • 9.5.6.2. Financial Performance
    • 9.5.6.3. Product Benchmarking
    • 9.5.6.4. Strategic Initiatives
  • 9.5.7. Chengdu Seamaty Technology Co., Ltd.
    • 9.5.7.1. Participant's Overview
    • 9.5.7.2. Financial Performance
    • 9.5.7.3. Product Benchmarking
    • 9.5.7.4. Strategic Initiatives
  • 9.5.8. SKYLA CORPORATION
    • 9.5.8.1. Participant's Overview
    • 9.5.8.2. Financial Performance
    • 9.5.8.3. Product Benchmarking
    • 9.5.8.4. Strategic Initiatives
  • 9.5.9. Boule Diagnostics.
    • 9.5.9.1. Participant's Overview
    • 9.5.9.2. Financial Performance
    • 9.5.9.3. Product Benchmarking
    • 9.5.9.4. Strategic Initiatives
  • 9.5.10. Bioevopeak Co., Ltd.
    • 9.5.10.1. Participant's Overview
    • 9.5.10.2. Financial Performance
    • 9.5.10.3. Product Benchmarking
    • 9.5.10.4. Strategic Initiatives

Chapter 10. Key Takeaways